Your browser doesn't support javascript.
loading
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.
Clarke, Jeffrey M; Gu, Lin; Wang, Xiaofei F; Stinchcombe, Thomas E; Stevenson, Marvaretta M; Ramalingam, Sundhar; Shariff, Afreen; Garst, Jennifer; Nixon, Andrew B; Antonia, Scott J; Crawford, Jeffrey; Ready, Neal E.
Afiliação
  • Clarke JM; Duke Cancer Institute, Durham, North Carolina.
  • Gu L; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
  • Wang XF; Duke Cancer Institute, Durham, North Carolina.
  • Stinchcombe TE; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
  • Stevenson MM; Duke Cancer Institute, Durham, North Carolina.
  • Ramalingam S; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
  • Shariff A; Duke Cancer Institute, Durham, North Carolina.
  • Garst J; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
  • Nixon AB; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
  • Antonia SJ; Duke Raleigh Hospital, Duke Cancer Institute, Durham, North Carolina.
  • Crawford J; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
  • Ready NE; Duke Raleigh Hospital, Duke Cancer Institute, Durham, North Carolina.
JTO Clin Res Rep ; 3(6): 100337, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35719867
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2022 Tipo de documento: Article